Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199"

Viruses. 2021 Aug 5;13(8):1546. doi: 10.3390/v13081546.

Sarah Stuckelberger¹, Guillaume Favre¹, Michael Ceulemans^{2

3}, Eva Gerbier¹, Valentine Lambelet¹, Milos Stojanov¹, Ursula Winterfeld⁴, David Baud¹, Alice Panchaud^{5

6}, Léo Pomar^{1

7}

¹ Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
² Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
³ Teratology Information Service, Pharmacovigilance Centre Lareb, 5237 MH 's Hertogenbosch, The Netherlands.
⁴ Swiss Teratogen Information Service, Service de Pharmacologie Clinique, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
⁵ Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland.
⁶ Service of Pharmacy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
⁷ School of Health Sciences (HESAV), University of Applied Sciences and Arts Western Switzerland, 1011 Lausanne, Switzerland.

Abstract

We would like to thank Stroobandt, S. and Stroobandt, R. for showing interest in our paper [...].